Introduced
Committee
Markup
Reported
Floor
Passed
Enacted
HRES.1285 119th Congress

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Status
In Committee
Latest Action
2026-05-14
Sponsor
DeGette, Diana (D-Colorado)
Official Source
Investability
0/100
Stage
COMMITTEE
Related Bills
0
Full Text
Unavailable
Alive
Yes
Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.
Full text not yet indexed for this bill. Check Congress.gov for the official text.
🔒 GovGreed Pro · Trading Intelligence on HRES.1285 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated recently.
Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records.
GovGreed is not affiliated with the U.S. Government. Not financial advice.